Meros Polymers
2009
FOUNDED
PRIVATE
STATUS
Angel
LATEST DEAL TYPE
(Cancelled)
$380K
LATEST DEAL AMOUNT
5
INVESTORS
Description
Owner and opeartor of a company for the development of nano-micellar substance to solve the problem of drug solubility. The company is focused on the development of a polymer platform technology that can carry drugs to specific areas of the body and improve drug effectiveness.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Other Pharmaceuticals and Biotechnology
Primary Office
- 1500 Manulife Place, 10180
- 101 Street
- Edmonton, Alberta T5J 4K1
- Canada
+1 (780) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Meros Polymers’s full profile, request a free trial.
Meros Polymers Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Angel (individual) | 20-Nov-2015 | $380K | Cancelled | Startup | ||
| 3. Grant | 01-Jan-2013 | 00000 | Completed | Startup | ||
| 2. Accelerator/Incubator | 01-Jan-2010 | Completed | Startup | |||
| 1. Angel (individual) | Completed | Startup |
Meros Polymers Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alberta Heritage Foundation for Medical Research Endowment Fund | Limited Partner | 000 0000 | 000000 0 | |||
| Canadian Institutes of Health Research | Corporation | 000 0000 | 000000 0 | |||
| Innotech Alberta | VC-Backed Company | 000 0000 | 000000 0 | |||
| National Research Council Canada | Government | 000 0000 | 000000 0 | |||
| TEC Edmonton | Accelerator/Incubator | 000 0000 | 000000 0 |
Meros Polymers Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Afsaneh Lavasanifar Ph.D | Chief Scientific Officer, Co-Founder and Vice-President |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »